SynAct Pharma AB Market Cap

SynAct Pharma AB has a market cap or net worth of 999.07 million as of March 6, 2026. Its market cap has increased by 25.84% in one year.

Market Cap

999.07M

Enterprise Value

946.87M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

17.84

Market Cap Chart

Since July 11, 2016, SynAct Pharma AB's market cap has increased from 63.75M to 999.07M, an increase of 1,467.12%. That is a compound annual growth rate of 32.97%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	999.07M	-17.11%
Dec 30, 2025	1.21B	189.20%
Dec 30, 2024	416.76M	32.69%
Dec 29, 2023	314.09M	-87.00%
Dec 30, 2022	2.42B	-34.75%
Dec 30, 2021	3.70B	242.52%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Xspray Pharma AB	1.01B
Cantargia AB	1.02B
Genovis AB (publ.)	1.10B
Medivir AB	837.10M
Infant Bacterial Therapeutics AB	674.92M
BioInvent International AB	1.49B
FluoGuide	544.43M
Saniona AB	2.01B

Market Cap Rankings